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Abstract
The cancer stem cell hypothesis has evolved into one of the most important
paradigms in cancer research. According to cancer stem cell hypothesis, so-
matic mutations in a subpopulation of cells can transform them into cancer stem
cells with the unique potential of tumour initiation. Stem cells have the poten-
tial to produce lineages of non-stem cell populations (differentiated cells) via a
ubiquitous hierarchal division scheme. Differentiation of a stem cell into (par-
tially) differentiated cells can happen either symmetrically or asymmetrically.
The selection dynamics of a mutant cancer stem cell should be investigated
in the light of a stem cell proliferation hierarchy and presence of a non-stem
cell population. By constructing a three-compartment Moran-type model com-
posed of normal stem cells, mutant (cancer) stem cells and differentiated cells,
we derive the replicator dynamics of stem cell frequencies where asymmetric
differentiation and differentiated cell death rates are included in the model. We
determine how these new factors change the conditions for a successful mutant
invasion and discuss the variation on the steady state fraction of the popula-
tion as different model parameters are changed. By including the phenotypic
plasticity/dedifferentiation, in which a progenitor/differentiated cell can trans-
form back into a cancer stem cell, we show that the effective fitness of mutant
stem cells is not only determined by their proliferation and death rates but
also according to their dedifferentiation potential. By numerically solving the
model we derive the phase diagram of the advantageous and disadvantageous
phases of cancer stem cells in the space of proliferation and dedifferentiation
potentials. The result shows that at high enough dedifferentiation rates even a
previously disadvantageous mutant can take over the population of normal stem
cells. This observation has implications in different areas of cancer research in-
cluding experimental observations that imply metastatic cancer stem cell types
might have lower proliferation potential than other stem cell phenotypes while
showing much more phenotypic plasticity and can undergo clonal expansion.
Keywords: cancer stem cell, evolutionary dynamics, selection, differentiation,
plasticity, de-differentiation, self-renewal, epithelial-mesenchymal transition.
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1. Introduction
According to clonal evolution theory, most tumours arise from single cells
through multiple genetic alterations accumulated over time. However, the can-
cer stem cell hypothesis suggests that cancer cells with similar genetic back-
ground originate from a transformed cell which can initiate the rest of tu-
mour population (Bonnet and Dick, 1997)(Lapidot et al, 1994)(Eppert et al,
2011)(Meacham and Morrison, 2013). This subpopulation of tumour initiating
cells, known as cancer stem cells, are hypothesized to be a result of somatic
mutations of a normal adult stem cell giving it a proliferative advantage and
as a result generating clonal outgrowth in the tissue which leads to the for-
mation of a neoplasm (Perou et al, 2000)(Sørlie et al, 2001)(Vogelstein et al,
2013). Combination of these mutation/proliferation mechanisms and microen-
vironmental factors leads to different stages of cancer progression (Hanahan and
Weinberg, 2000)(Hanahan and Weinberg, 2011), which results in genetically and
phenotypically heterogeneous tumours (Notta et al, 2011).
Stem cells can divide both symmetrically into two daughter stem cells (self-
renewal) or two daughter progenitor cells (full differentiation), or asymmetrically
into a daughter stem cell and a progenitor cell (partial differentiation) . Pro-
genitor cells then divide hierarchically into a population of fully differentiated
functional tissue cells which lack proliferative potential (Morrison and Kimble,
2006). This polarity in cancer stem cell division is observed in different cancer
types. For breast carcinomas, it has been shown that activating the ErbB2
oncogene increases the self-renewal potential of cancer stem cells significantly
(Cicalese et al, 2009). Similarly, p53 inactivation leads to not only almost im-
mortal stem cells but also a higher divisional polarity (Cicalese et al, 2009).
p53 is also reported to impose an asymmetric proliferation potential on other
non-stem cell linages (Rambhatla et al, 2001); see also (Caussinus and Gonzalez,
2005).
In addition to the tumour initiating potential of cancer stem cells, another
distinctive feature of cancer cells is their high phenotypic plasticity. One aspect
of such plasticity is the dedifferentiation potential possessed by stem cell progen-
itors. During dedifferentiation progenitors (or differentiated cells) can transform
back spontaneously into a stem cell thus lending further credence to the vivid
concept of cancer stem cells as tumour initiating cell (Marjanovic et al, 2013).
Recent in-vitro experiments have demonstrated the dedifferentiation potential
of different cancer type cell lines. For breast cancer, purified populations of non-
stem cells, CD44low/CD24hi (basal and luminal cell lines), created a population
of CD44hi/CD24low, which is a marker for stemness (Gupta et al, 2011). It
has been also shown that a population where the majority are non-stem cells,
CD44low/CD24hi, gives rise to a higher mammosphere formation rate which
is a measure of stemness (Chaffer et al, 2011). The role of dedifferentiation in
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intestinal tumorigenesis is investigated in (Schwitalla et al, 2013), where it is
shown that elevating the levels of the transcription factor NF−κB, which mod-
ulate Wnt signaling, induces dedifferentiation in the (non-stem cell) intestinal
epithelial cell population and thus can lead to tumourigenesis. In the context of
leukaemia, the leukemia-initiating cell marker CD34+CD38− has been observed
in the fraction of non-leukemia initiating cells (Bonnet and Dick, 1997)(Sarry
et al, 2011).
It has been suggested that as cancer progresses towards more aggressive
metastatic phenotypes, the dedifferentiation potential increases (Marjanovic
et al, 2013). The dedifferentiation of non-stem cells may arise due to (stochasti-
cally) genetic or epigenetic mutations, or the epithelial-mesenchymal transition
(EMT), a cellular differentiation process wherein epithelial cells adopt mes-
enchymal features (Marjanovic et al, 2013). It has been shown that EMT in-
duced cells have a higher dedifferentiation potential while at the same time they
display features resembling stem cell (Chaffer et al, 2013)(Scheel and Weinberg,
2011) (Mani et al, 2008). Thus, beside the mutation/clonal expansion model
of cancer progression which leads to genomic heterogeneity in the tumour pop-
ulation, inclusion of hierarchal stem cell proliferation and the dedifferentiation
potential of cells leads to more phenotypic heterogeneity inside a tumour. More
importantly, cell plasticity shadows the concept of stem cells, in the sense that
we cannot compare the two populations of normal and cancer stem cells com-
peting via their corresponding proliferation strengths, but rather the population
of non-stem cells has to be included in the picture of the selection process and
Darwinian evolution of the tumour.
Mathematical models of selection processes so far have treated the selec-
tion mechanism among cancer stem cell populations and normal population
assuming higher division rate for mutants due to activation and inactivations of
oncogenes/tumour suppressor genes that regulate the growth factor signalling
pathways inside the cell. These models were able to successfully describe the
selection process occurring prior to each new clonal expansion (due to a new
mutation). The dynamics of tumour suppressor gene inactivation in particular
has been investigated in the literature in detail (Komarova et al, 2003)(Nowak
et al, 2004)(Michor et al, 2004); see (Attolini and Michor, 2009) for a thorough
review of evolutionary modelling in cancer. However, there has not been much
work with regard to stem cell hierarchy proliferation potential and its effect on
selection dynamics. Some recent works have focused on the asymmetric nature
of stem cell division. (Dingli et al, 2007) studied the time to fixation of mu-
tant stem cell selection using a simplified birth-death model of two stem cell
population which divides asymmetrically, ignoring the population progenitors
and differentiated cells (perhaps for simplicity). A recent computational study
by Sprouffske et al (Sprouffske et al, 2013), has investigated the effect of an
asymmetric division scheme for stem cells by simulating stem cells with random
fitness and have discussed Darwinian selection and the existence of disadvanta-
geous subpopulations in the formation of neoplasms. Shahriyari and Komarova
(?) has also addressed the evolutionary advantage/disadvantages of symmetric
versus asymmetric differentiation by constructing a Moran-type process for one
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and two-hit mutation models and have analyzed the effect of differentiated cell
compartment in the effectiveness of the mutations among stem cell compart-
ment. More recently, Jilkine and Gutenkunst (?) considered a stochastic model
for differentiation and dedifferentiation and investigated time to mutation ac-
quisition in the presence of dedifferentiation mechanism for progenitors of stem
cells. They also discussed how asymmetric versus symmetric differentiation can
affect the efficiency of dedifferentiation process. The cancer stem cell hypoth-
esis has also been applied in the context of drug resistance as an evolutionary
process by Leder et al (Leder et al, 2010).
The present work aims to provide a general framework to study the selection
dynamics of cancer versus normal stem cells by including asymmetric differenti-
ation, in addition to stem cell self-renewal. This introduces a more challenging
mathematical model which now contains two competing stem cell populations
and a third differentiated cell compartment, which now both stem cells popu-
lations are competing with. By introducing a Moran-type stochastic model for
this three-compartment model, we derive replicator-type dynamics for the three
populations of cancer stem cells, normal stem cells and differentiated cells as
a function of time. We show that the condition for successful invasion by the
cancer stem cells not only depends on their higher division rate or lower death
rate, but also on differentiation rate or polarity of their asymmetric division. In
constructing the birth-death model we assume three independent parameters for
the death rates of mutant stem cells, normal stem cells and the differentiated cell
population. An important feature of our model is that dedifferentiation events
can be naturally added to the model. We discuss dedifferentiation (assumed
only for cancer stem cells) in detail and show that the proliferation advantage is
not only a function of relative fitness of two stem cells and their corresponding
differentiation rates but also depends on the strength of plasticity and on the
population of non-stem cells. We plot a phase diagram between advantageous
and disadvantageous regimes in the space of fitness, plasticity and, differenti-
ation probabilities. We show that assuming finite dedifferentiation rates (con-
sistent with numerical estimate from experiments) a seemingly disadvantageous
mutant can successfully initiate clonal expansion into a neoplasm.
The paper is organized as follows: In Sec. 2 we formulate a Moran-type
model of stem cell differentiation and dedifferentiation and report the replica-
tor dynamics in the presence of differentiation and dedifferentiation potentials.
We also discuss the analytical result of the fixation time for this model in the
absence of dedifferentiation. In Sec. 3 we discuss numerical solutions of the
replicator dynamics and investigate the population dynamics and average time
to fixation of a mutant stem cell as one varies division rates of the stem cell
population, relative death rates of stem cells and differentiated cells and dif-
ferentiation probabilities. Similarly, we look at time to fixation and whether
a mutant is advantageous or disadvantageous by varying both relative division
rates and dedifferentiation potential. In Sec. 4 we discuss the implications for
cancer therapeutics and also possible future directions of investigation.
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2. Replicator Dynamics of Differentiation and Dedifferentiation
We consider a model of two stem cell populations and a population of par-
tially/fully differentiated cells (Fig. 2). Normal stem cells divide with a rate
r1 and die with rate d1 per generation. In each division event, a stem cell can
divide (1) symmetrically into two daughter stem cells with probability ω1, (2)
asymmetrically into one daughter stem cell and one progenitor with probability
u1 and (3) fully differentiate into two daughter progenitor cells with probability
v1 (Fig. 3). The probabilities ω1, u1 and v1 add up to unity. Similarly, mutant
stem cell proliferation and death rates are denoted by r2 and d2. Correspond-
ingly, self-renewal and differentiation probabilities are ω2, u2 and v2. In the
hierarchal stem cell proliferation scheme, the number of transient progenitors
are finite thus by including all differentiated cell population into one compart-
ment, we assume that the only possibility for this population to increase is the
case in which a stem cell differentiates symmetrically or asymmetrically. Thus
we assume that the differentiated compartment lacks proliferation potential of
its own. The death rate of differentiated cells are commonly higher than normal
and cancer stem cells and is denoted as dD.
To biologically justify the model described above, consider an intestinal crypt
which constitutes part of the colon. The crypt has a U-shaped one-dimensional
arrangement of cells where at the bottom, few stem cells proliferate and augment
the proliferation of the rest of the cells. On top of the stem cells, there is a range
of transient progenitor cells which constitute most of the body of the crypt and
end up to a population of fully functional differentiated cells. Due to both
geometrical constraints and homeostasis regulation, the total population of the
whole crypt - and not only the population of stem cells at the bottom - can be
considered constant (see Fig. 1).
S1 + S2
D
stem cells
partially  
differentiated
fully 
differentiated
Figure 1: Schematics of three-compartment model of cancer/normal stem cell and differenti-
ated cells for an intestinal crypt.
We consider a Moran-type of birth-death process in which, at every time
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step, one stem cell is chosen to divide at random with probability proportional
to its fitness. The cell division includes all the possible self-renewal and differ-
entiation events. Differentiated cells do not contribute to birth events as they
lack any proliferation potential. At the same time step, another stem cell or
differentiated cell is picked at random to die. This construction keeps the total
population of the whole system of stem cells plus differentiated cells constant.
We can examine the dynamics of the selection mechanism by analyzing this
model. Notice the differences between this model and the conventional Moran
model, where there are only two populations of normal and mutant cells and at
every time step a birth and death event occurs. In our model, birth events do
not necessarily increase the total number of either of the stem cell populations
but rather can be a differentiation process in which the non-stem cell popula-
tion increases in number, while the number of stem cells is reduced or remains
constant. Our construction is also different from that of (Dingli et al, 2007)
which incorporated differentiation events as an independent death event. For a
conventional Moran model, the population dynamics is described by a replicator
ODE for the fraction of mutant stem cells, x(t) (Moran et al, 1962)(Wodarz and
Komarova, 2005),
dx(t)
dt
=
(r − 1)x(1− x)
(1 + (r − 1)x) . (1)
This can straightforwardly be generalized to arbitrary birth and death rates r
and d,
dx(t)
dt
=
(r˜ − 1)x(1− x)[
(
r2
r1
− 1)x+ 1)
] [
(1− d1
d2
)x+
d1
d2
] , (2)
r˜ =
r2
r1
d1
d2
. (3)
If r˜ > 1 the mutant is advantageous, if r˜ < 1 the mutant is disadvantageous.
The case r˜ = 1 is the marginal neutral limit where stochastic fluctuation and
finite-population effects are important in determining the fate of a single mu-
tant. In the presence of asymmetric differentiation and the third population of
(differentiated) cells, we generalize the above simple criteria for a mutant stem
cell being advantageous. The population dynamics of the two stem cell popu-
lations can be obtained as a non-linear system of coupled ODEs (see Appendix
A),
dx1(t)
dt
=
r1α1dD · x1 − x1d1 (r1x1 + r2x2) + r1α1x1((d1 − dD)x1 + (d2 − dD)x2)
(r1x1 + r2x2)((d1 − dD)x1 + (d2 − dD)x2 + dD) ,
dx2(t)
dt
=
r2α2dD · x2 − x2d2 (r1x1 + r2x2) + r2α2x2((d1 − dD)x1 + (d2 − dD)x2)
(r1x1 + r2x2)((d1 − dD)x1 + (d2 − dD)x2 + dD) ,
(4)
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q Partial/Full !
Differentiated!
Cells
Cancer !
Stem Cell
Normal !
Stem Cell
d2
d1
dD
r2↵2
r1↵1
r1(1  ↵1)
r2(1  ↵2)
Figure 2: The two competing stem cells (normal =blue, mutant = red) can self-renew or
differentiate with rates r1,2α1,2 and r1,2(1 − α1,2), and die with rates d1,2. The rest of the
population of progeny and differentiated cells are indicated as green which can either die, dD
or dedifferentiate into the cancer stem cell compartment (q).
where x1,2 are the frequencies of the normal and cancer stem cells (x1,2 =
i1,2/N where i1,2 are the corresponding stem cell populations), the coefficients
α1,2 = ω1,2 − v1,2 indicate the effective self-renewal rate. Notice that now
x1+x2+xD = 1, where xD is the fraction of the differentiated cells. Equation 4
is the replicator dynamics of caner stem cells in the presence of differentiation.
Attractive fixed points of Eq. 4 determine the possible steady state frac-
tions of the two stem cell populations. In the absence of any game theoretical
interactions there is no coexistence of the two populations. Fixed point of Eq.
4 corresponding to domination of the mutant population is,
x∗1 = 0, x
∗
2 =
α2dD
(1− α2)d2 + α2dD , (5)
where the value x∗2 also indicates the final fraction of mutant stem cells while the
rest of the fraction is taken by differentiated cells. The effective proliferation rate
of each stem cell population is thus determined by r1,2α1,2 = r1,2(ω1,2 − v1,2).
Similarly, the fixed point of normal stem cells lies along the x1-axis and is given
by,
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iiDedifferentiation
Figure 3: The replication-death Moran-type model. The two competing stem cell populations
are indicated by blue and red (normal =blue, mutant = red). The rest of the population
of progeny and differentiated cells are indicated as green. In each time step one replication
and one death elementary process occurs. In the presence of dedifferentiation, two further
composite events happen: a differentiated cell divided into a cancer stem cell and a cancer
stem cell death occurs.
x∗1 =
α1dD
(1− α1)d1 + α1dD , x
∗
2 = 0. (6)
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The phase portrait for Eq. 4 is plotted in Fig. 4. In Fig. 4 one can see that
there are two fixed points for this model, x∗1,2 along each of the two x1 and x2
axes. It is importance to notice that one of the two fixed points, x∗1,2 is globally
attractive and the other is a saddle-point. The attractive fixed-point determines
the advantageous population that is capable of taking over a fraction of the
whole population. As the rest of the population is made of only non-stem cells.
A straightforward stability analysis for both fixed points leads to an algebraic
condition to determine the advantageous versus non-advantageous phenotypes
in the presence of differentiation. One can readily check the following condition
for a successful mutant,
r2(ω2 − v2)
d2
≥ r1(ω1 − v1)
d1
. (7)
It turns out that the change in the differentiated cells death rate (which in
fact is representative of how fast transient cells are dividing and fully-differentiated
cells are dying) does not change the critical value of the effective fitness that
determines a neutral system. Variation in the value of dD, however, does change
the fraction of mutant stem cells in the stationary state and also affects how
long it takes to reach fixation (time to fixation).
The denominator of Eq. 4 is quite essential in determining the time to
fixation for an advantageous mutant. One can derive (see Appendix B) an
analytical result for this fixation time in the case of equal death rates d1,2,D = 1,
tF =
(
rα2 + α1
rα2 − α1
)
lnN − lnα2, (8)
where 1/N is the initial fraction of the mutant stem cells (see Appendix B).
As differentiation probabilities increase the second term contribution abruptly
increases leading to higher time to fixation. Interestingly u1,2 = v1,2 = 1/3 is
the limit where time to fixation blows up to infinity.
It is also instructive to follow the trajectory, starting with one mutant stem
cell (x2,i = 1/N). As indicated by a horizontal trajectory in Fig. 4, the fre-
quency of mutant cells remain constant indicating that initially differentiation
of normal stem cells is a major mechanism until the trajectory gets close to
the fixed point of normal cells, i.e. differentiated cells get saturated. The rest
of the trajectory is a diagonal line that connects the two fixed points to each
other. For the case of identical differentiation probabilities, α1 = α2 we get
x2 = α − x1, indicating that the selection dynamics, similar to the Moran
model, is at work, and the effect of differentiation is a shift in the effective total
population (N → N − nD). In the case of different differentiation rates which
is of interest to us, we can see the line of attraction does have a slope and thus
differentiation effect acts to change the effective total population and also to
amplify the frequency of the mutant population.
Beginning from a small differentiated cell fraction (see Fig.4), we see that
the trajectories tends to stay at an almost constant value for x2, while x1 is de-
creasing, i.e the competition is initially between differentiated cells and normal
9
Figure 4: The phase portrait of average populations for the stochastic growth equations for
(a) r1 = 1.0, r2 = 1.2, u1,2 = 0.1, v1,2 = 0.0, d1,2,D = 1.0 (b) r1 = 1.0, r2 = 1.2, u1 = 0.1, u2 =
0.3, v1,2 = 0.0, d1,2,D = 1.0. Mutant fixed point along vertical axis becomes unstable as the
differentiation probability u2 increases from 0.1 to 0.3.
cells. As time passes and the differentiated cell population reaches a saturated
value the effective competition is going to be between the two stem cell popu-
lations. In three-population models of selection, this sequential behaviour for
selection is known as Hill-robertson interference (for example see (?)). This is
in fact an important observation, as the model predicts that there is a always a
(relatively large) pool of differentiated cell population present as the two stem
cell populations are competing thus when dedifferentiated events are going to
be taken into account (next section).
2.1. Dedifferentiation and Plasticity
We can introduce dedifferentiation into this model in a similar fashion as
a back-mutation event for differentiated cells. To incorporate mutation events
into a Moran process, we can regard it as an asymmetric division event where
one phenotype asymmetrically divides and gives rise to one daughter cell of
its own type and one daughter cell of the mutant phenotype (see (Komarova
et al, 2003)(Wodarz and Komarova, 2005)). In the case of plasticity - as back
mutation- we assume that a differentiated cell can asymmetrically divide into
a daughter differentiated cell and a daughter mutant stem cell. The rate of
division is indicated by q. This is accompanied by a death event of either a
differentiated cell or a mutant stem cell with the same death rate as model
indicates. The slight difference that appears in our construction is that we need
a mutation event for differentiated cells to transform back into mutant stem cells
and into the normal population. Thus, only the differentiated cell division are
accompanied with either mutant or differentiated cell death events. Thus there
is a correlation between birth-death dedifferentiation events by construction.
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As normal stem cells are assumed to be well regulated and follow the stem
cell proliferation hierarchy we ignore the possibility of dedifferentiation for the
normal population.
To reduce the number of parameters, we assume the death rates of all pop-
ulations are equal, d1,2,D = 1.0. Now the population dynamics can be written
in terms of the ratio of r2 and r1 and the dedifferentiation rate, q. Derivation
of the transition probability for the dedifferentiation events are presented in
Appendix A,
dx1(t)
dt
=
r1α1 · x1 − x1 (r1x1 + r2x2)
((r1 − q)x1 + (r2 − q)x2 + q) ,
dx2(t)
dt
=
r2α2 · x2 − x2 (r1x1 + r2x2) + q(1− x1 − x2)2
((r1 − q)x1 + (r2 − q)x2 + q) , (9)
where the term q(1− x1 − x2)2 is added to the dynamics of mutant cells. The
dynamics of normal stem cells are untouched other than modification to the
total possible events (denominator of equations) which now includes an effective
proliferation event of differentiated cells with rate q.
In the presence of dedifferentiation, the fate of a new mutant is not only
determined by its relative proliferation rate, r but also by the dedifferentiation
rate of non-stem cell population, q. Notice that the differentiation dynamics is
essential and has to be included, as the differentiation rates essentially deter-
mine what fraction of the total population is made up of differentiated cells and
thus affect the dedifferentiation rate. For example if differentiation rates are
low and we begin with a population of normal stem cells and introduce a dis-
advantageous mutant to this system, the mutant will become extinct. However,
if the differentiation rates are high enough the population of differentiated cells
- created via differentiation - can actively contribute to increasing the mutant
population.
In the construction of the model we did not make a distinction between dif-
ferentiated cells with the capability of phenotypic plasticity and normal differen-
tiated cells. Dividing the non-stem cell population into plastic and non-plastic
populations, however, will only change the effective value of the dedifferentia-
tion rate, q, and is not crucial for our analysis. For stochastic analysis of the
fixation probability, however, such a distinction might be needed.
In the presence of dedifferentiation, the fixed point of mutant cells remains
along the x2-axis, given by,
x∗1 = 0, x
∗
2 =
1
2
−α2r2 + 2q +
√
α2r2(α2r2 − 4q) + 4qr2
q − r2 , (10)
while the (previous) fixed point of normal cells now shifts up from the x1 axis,
having both components nonzero. The components of this fixed point can be
described by algebraic expressions in terms of r1,2, α1,2 and q. In the limit of
α1 = 1 and r1 = 1,
x∗1 =
(α2 + q)r
2
2 − 2qr2 + q − r2
q(r2 − 1)2 , x
∗
2 =
−α2r2 + 1
q(r2 − 1)2 . (11)
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Notice that even in the absence of both stem cell populations at t = 0 the
system will evolve to one of the two fixed points which contain stem cells, due
to phenotypic plasticity.
We have depicted the phase portrait of the stem cell dynamics in Fig. 5.
While the vertical fixed point of mutant stem cells is not globally stable for
r2/r1 = 0.8, upon introduction of a finite value of dedifferentiation, the role of
the two fixed points switches and the mutant is now advantageous (Fig. 5b).
Figure 5: The phase portrait of average populations for (a) r1 = 1.0, r2 = 0.8, u1,2 =
0.5, v1,2 = 0.0, d1,2,D = 1.0 with dedifferentiation rate q = 0.0. (b) Same parameter val-
ues as part (a) but q = 0.5 now. The important change here is that the fixed point x∗1 remains
along the horizontal axis, indicating the possibility of extinction of mutant cells, while the
new fixed point (previously called x∗2 now have non-zero values of normal and mutant stem
cells indicating the possibility of co-existence between the two population in the presence of
dedifferentiation. Notice the co-existence can only occur when the disadvantageous mutant
becomes advantageous in the presence of dedifferentiation).
In the next section we analyze the numerical solutions of both replicator
dynamics in detail. The numerical solutions will let us calculate the time to
fixation of the model as a function of proliferation and differentiation rates of
normal and cancer stem cells as well as death rates of all three populations.
3. Numerical Results
3.1. Time to Fixation and Steady State Fraction of Cancer Stem Cell
We numerically integrate the system of equations in Eq. 4 and plot (Fig. 6)
the stem cell frequencies as function of proliferation and death rates in addition
to differentiation probabilities. In addition to time to fixation, the value of
the steady state fractions can be read off from these plots. In most of the
cancer initiation cases, the population of normal and differentiated cells are
in equilibrium prior to introduction of the mutant stem cell. The equilibrium
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fraction between stem cells and differentiated cells differ from tissue to tissue but
normally stem cells constitute a small minority. This is reflected in our choice
of initial conditions. The initial frequency of normal stem cells is taken to be
0.5 while the mutant frequency is 0.01. In Fig. 6a proliferation parameters
read as r2 = 1.2, r1 = 1.0, d1,2,D = 1.0. As it is believed that most of the
differentiation events occur asymmetrically, i.e., v1,2  1, we choose v1,2 = 0.0
and look at the population dynamics of both stem cell species as u1 is varied for
two different values of u2 = 0.1, Fig. 6 (top), and u2 = 0.3, Fig. 6 (bottom).
The mutant stem cell is always assumed advantageous with r2/r1 = 1.2. Notice,
while relative fitness in the absence of differentiation is bigger than unity, for
low differentiation rates of normal cells and high differentiation rates of cancer
stem cells Fig. 6 (u1 = 0.1, u2 = 0.3) the normal stem cells have a selective
advantage. Also the increase in time to fixation is apparent as one decreases the
differentiation rate of normal stem cells. For the normal stem cell frequency,
there is a peak at early times which begins to decrease monotonically. As
discussed in the previous section, this early increase in the population of both
stem cells indicates that there is an early competition between stem cells and
differentiated cells before differentiated cells reach saturation and stem cells
begin to compete with each other. As the values of differentiation probabilities
is decreased we observe an increase in time to fixation (time to reach plateau
in Fig. 6) . This is in accordance with the exact analytical result for time to
fixation tF, Eq. 8.
Time to fixation is also plotted directly from integration of Eq. 4 as a
function of both relative fitness and differentiation rates. This is plotted in Fig.
7. Again, as is expected from Eq. 8, time to fixation dramatically reduces as
division ratio r2/r1 increases as a function of asymmetric differentiation rate of
cancer stem cells.
As discussed in the previous section, the effective fitness is in fact indepen-
dent of the value of dD as can be seen from the condition in Eq. 7. However,
changing dD affects the final frequency of mutant stem cells. This can be seen
in Fig. 8. Fig. 8a is plotted with parameter values r1 = 1, r2 = 1.2, u1,2 =
0.3, v1,2 = 0.0, d1,2 = 1.0, dD=1.0 (magenta), 3.0 (green), 5.0 (blue), 7.0 (red).
Finally, we plot the fraction of mutant stem cells as a function of both dD and
the asymmetric differentiation rate of mutant cells, u2 in Fig. 9.
3.2. Cancer Stem Cell Dynamics in the Presence of Dedifferentiation
In the presence of dedifferentiation Eq. 9 can be solved for different values of
dedifferentiation and proliferation rates of normal and cancer stem cells. Pop-
ulation dynamics of stem cell frequencies is plotted (Fig. 10) as differentiation
rates change. In Fig. 10 (top) a disadvantageous mutant with r2/r1 = 0.8 is
assumed. As one can see, upon increasing the dedifferentiation rate from 0 to
0.6, the mutant invasive fate changes. For q = 0.2, 0.4, 0.6, as a matter of fact,
the mutant is advantageous. Change of differentiation rates also play an impor-
tant role in the dedifferentiation dynamics. Dedifferentiation not only depends
on the rate of conversion and phenotype switching of non-stem cells but also
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Figure 6: Stem cell frequencies as a function of time for various division rates and differen-
tiation probabilities: (top)r1 = 1, r2 = 1.2, u1 = 0.2 (magenta), 0.4 (green), 0.6 (blue), 0.8
(red), u2 = 0.1, v1,2 = 0.0, d1,2,D = 1.0. ( bottom) r1 = 1, r2 = 1.2, u1 = 0.1 (magenta), 0.2
(green), 0.3 (green), 0.3 (blue), 0.4 (red), 0.5 (black), u2 = 0.3, v1,2 = 0.0, d1,2,D = 1.0.
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tF
r u2
tF
Figure 7: (Average) time to fixation as a function of relative fitness and differentiation rates
left: tF as a function of r2/r1 for u1 = 0.5 and u2=0.2 (magenta),0.3 (green), 0.4 (blue), 0.5
(red). Times are measured in units of generation.
Figure 8: Stem cell fractions for parameters r1 = 1, r2 = 1.2, u1,2 = 0.3, v1,2 = 0.0, d1,2 =
1.0, dD=1.0 (magenta), 3.0 (green), 5.0 (blue), 7.0 (red).
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Figure 9: Mutant stem cell fraction in the steady state as a function of differentiation rate
u2 (u1 = u2, v1,2 = 0.0) and the death rate of differentiated cells, dD. Notice that the limit
of low death-rate of differentiated cells is not a physical result. In fact, in tissues such as
intestinal crypt, the differentiated cell death rates are significantly higher than stem cells.
on the population of non-stem cells itself. Based on our model this is not sur-
prising that as the differentiation rate u1,2 (in this case) increases the originally
disadvantageous cancer stem cell becomes advantageous, Fig. 10(bottom).
Condition under which the cancer stem cells (in presence of a finite differen-
tiation rate (u1,2), dedifferentiation rate (q) and relative proliferation (r2/r1))
are advantageous or not, is a nontrivial question. As can be seen from the fixed-
point analysis, the two fixed points corresponding to a full fixation of mutant cell
(versus partial) in the final population always exist. The condition for having
a successful mutant depends on when the mutant fixed point becomes globally
attractive. We have calculated this numerically by diagonalizing the Jacobian
matrix of Eq. 9, and looking at the point when the second eigenvalue becomes
negative (one eigenvalue corresponding to x2 direction is always attractive thus
we only need to look at the sign change of the other eigenvalue).This leads to a
phase diagram for successful and unsuccessful mutants as function of r = r2/r1
and q. Fig. 11 shows the results for two different values of differentiation rates
u1,2= 0.3 (left) and u1,2 = 0.7 (right). The higher differentiation rate helps the
mutant to shift the neutral critical point (i.e. r = 1 for q = 0) faster to lower r
as q increases. Fig. 12 shows a 3D plot of such a phase diagram as all the three
relevant parameters in the model change.
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Figure 10: Stem cell dynamics in the presence of differentiation. Top: Dynamics of both
mutant and normal stem cell frequencies for different values of dedifferentiation rate q, while
rest of parameters are kept constant at r1 = 1, r2 = 0.8, u1,2 = 0.3, v1,2 = 0.0, q = 0.0
(magenta), q = 0.2 (green), q = 0.4 (blue), q = 0.6 (red). Bottom: Dynamics of populations
as differentiation rate varies: r1 = 1, r2 = 0.8, v1,2 = 0.0, q = 0.2, u1,2 = 0.2 (magenta),
u1,2 = 0.4 (green), u1,2 = 0.6 (blue), u1,2 = 0.8 (red).
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advantageous
dis-advantageous
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Figure 11: Phase diagram of dis-advantageous/advantageous mutant in the space of pro-
liferation rate (r2 represents relative proliferation rate as r1 = 1.0). Three different plots
correspond to different value of differentiation probabilities.
q
Figure 12: Three dimensional phase-diagram for dedifferentiation rate of cancer stem cells q,
proliferation rate r2 (r1 = 1.0) and asymmetric differentiation probability u2. (u2 = u1, v1,2 =
0.0). The curve indicate the neutral limit. All points in the phase space in the left belong to
an dis-advantageous mutant case.
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4. Discussion and Implications on Cancer Therapeutics
In this work we constructed a general model of stem cell selection dynamics
by including the population of differentiated cells into a Moran-type model which
governs the stochastic dynamics of both stem cell and non-stem cell species at
the same time. Although the non-stem cell (differentiated) population lacks
proliferative potential its population can increase through the differentiation of
stem cells. Our model allows us to proceed with investigating the conditions for
having a successful mutant stem cell as a function of differentiation probabilities
as well as the proliferation and death rates. Beside the competition between two
stem cells the model now can describe competition between stem cells and non-
stem cells which resemble itself as the fraction of the stem cells in the steady
state. The replicator dynamics that is derived for stem cell frequencies can
predict the average time to fixation which is in agreement with previous known
results for the Moran model in the limit of no differentiation.
The above construction allows us to approach theoretically the question of
dedifferentiation and phenotypic plasticity that has been observed in recent ex-
periments and which is believed to be an important factor at the latest stages of
cancer. By including dedifferentiation events into our replicator dynamics, we
are able to determine the fate of a cancer stem cell not only by its proliferation
potential but also based on the dedifferentiation rate and overall differentiation
parameters. We derive a 3D phase diagram that determines in what regions of
(proliferation, dedifferentiation, differentiation) space the cancer (mutant) stem
cell is successful. Interestingly, the phenotypic heterogeneity that is believed to
be a result of cell plasticity is seen in our model in the presence of dedifferen-
tiation. Due to the plastic nature of differentiated cells even a disadvantageous
mutant will not completely go extinct but rather keepsis preserved as a small
subpopulation in the final population of the system and can co-exist with the
normal stem cell population.
Notice that due to the complicated nature of adapting hierarchal prolifera-
tion scheme of stem cells into constant-finite population model(s) of selection
dynamics, we have had to keep things simplified. Thus the population of the
differentiated cells generated by either the cancer stem cells or normal stem
cells are both included in one compartment. The justification for this assump-
tion, is that in equilibrium there is a relatively large pool of differentiated cells
that then due to their plasticity (at least a fraction of them) can be expected
to contribute to an influx of differentiated cells that transform back into caner
stem cells. The lack of any experimental observations to distinguish between
plastic and non-plastic differentiated cells has led us to keep the simplest model
possible. However, the reader should be cautious since for small populations
of differentiated cells we might expect some distinction between a lineage of
differentiated cells derived from cancer stem cells from one generated by normal
stem cells. This will be the subject of future work.
The implications of the cancer stem cell dynamics for cancer therapeutics
is also important. The evolutionary dynamics of drug resistance has been dis-
cussed in the literature in some detail (Iwasa et al, 2006) (see also (Dingli and
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Michor, 2006)(Foo and Michor, 2009)). The idea in previous modelling schemes
is that due to strong genetic heterogeneity of stem cells inside the tumour, there
is a finite probability of having a particular drug-resistant phenotype which upon
chemotherapy (or radiotherapy) can take over the system and replenish the can-
cer stem cell pool even faster than before. Inclusion of phenotypic plasticity,
as we discussed in this model, however, suggests an alternative picture. In this
picture tumour heterogeneity is due to diverse dedifferentiation programs which
result in a set of plastic differentiated cells transforming back into a variety
of cancer stem cell phenotypes. Thus even if the therapy kills all cancer stem
cells in the tumour, as long as a small population of plastic non-stem cells ex-
ist there is a finite chance for them to create a drug-resistant phenotype. Due
to a much higher rate of dedifferentiation (relative to somatic mutations) this
alternative picture can explain the solidity of the drug-resistance mechanism in
many tumours. Our model also suggests that this rate strongly depends on the
number of dedifferentiation channels developed in the tumour (which correlates
with the level of plasticity and aggressiveness of the tumour phenotypes). Drug
resistance due to dedifferentiation also predicts a dependence of resistance on
the size of the tumour after the therapy. As a matter of fact when the tumour
is in its early stages, the dedifferentiation rate is low, the heterogeneity is also
small, and thus therapy eradicates or reduces the size of the tumour signifi-
cantly. However, if the drug-resistant colony is already formed and the main
mechanism of their population increase is due to their self-renewal capability,
then the cancer therapy might not work due to both increased rate of plasticity
and also inability to overcome the resistant colony.
There are also important implications related to the epithelial-mesenchymal
transition (EMT), a cellular differentiation program wherein epithelial cells
adopt mesenchymal features. It is known that cancer cells that undergone EMT
have less proliferation potential (division rate) (Gatenby and Gillies, 2008) but
much higher plasticity and dedifferentiation than their progenitors. The phase
diagram derived in the previous section can answer the paradoxical situation
that even though EMT cells are assumed to be disadvantageous inside a tu-
mour they can undergo clonal expansion and defy extinction and eventually
pay a significant role in the highly heterogenous population of the tumour.
5. Appendix A
Individual events of replication of a normal or mutant stem cell and/or death
of a mutant or normal stem cell or a differentiated cell are given by,
Preplication,i =
ωiri · ni
r1n1 + r2n2
(ωi → ui, vi)
Pdeath,k =
dknk
d1n1 + d2n2 + dDnD
, i = 1, 2 k = 1, 2, D. (12)
All possible combinations of these replication and death events leads to tran-
sition probabilities for the Moran-type model introduced in the text (Fig. 3).
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The master equation for such a three-population death-birth process can be
written as,
N−1
∂φ(n1, n2; t)
∂t
= P−,0(n1 + 1, n2)φ(n1 + 1, n2; t) + P+,0(n1 − 1, n2)φ(n1 − 1, n2; t)
+ P 0,−(n1, n2 + 1)φ(n1, n2 + 1; t) + P 0,+(n1, n2 − 1)φ(n1, n2 − 1; t)
+ P−,+(n1 + 1, n2 − 1)φ(n1 + 1, n2 − 1; t) + P+,−(n1 − 1, n2 + 1)φ(n1 − 1, n2 + 1; t)
+ P−,−(n1 + 1, n2 + 1)φ(n1 + 1, n2 + 1; t) + P−2,0(n1 + 2, n2)φ(n1 + 2, n2; t)
+ P 0,−2(n1, n2 + 2)φ(n1, n2 + 2; t)− {P−,0(n1, n2) + P+,0(n1, n2)
+ P 0,−(n1, n2) + P 0,+(n1, n2) + P−2,0(n1, n2) + P 0,−2(n1, n2}φ(n1, n2; t), (13)
where φ(n1, n2; t) is the probability density of having n1 and n2 stem cells
(normal and mutant) at time t. P±,±(n1±1, n2±1) are transition probabilities
to lose or gain one normal or mutant stem cells. N−1 is inserted to keep the
continuum time limit consistent with discreet time (∆t = 1/N). Introducing
the notation,
Nr = r1n1 + r2n2
Nd = d1n1 + n2d2 + dD(N − n1 − n2), (14)
the transition probabilities in the absence of dedifferentiation are,
P+,0(n1, n2) = r1ω1n1 · dD(N − n1 − n2)/(NrNd),
P−,0(n1, n2) = {r1u1n1 + r2u2n2} · d1n1/(NrNd) + r1v1n1 · dD(N − n1 − n2)/(NrNd),
P 0,+(n1, n2) = r2ω2n2 · dD(N − n1 − n2)/(NrNd),
P 0,−(n1, n2) = (r1u1n1 + r2u2n2) · d2n2/(NrNd) + r2v2n2 · dD(N − n1 − n2)/(NrNd),
P+,+(n1, n2) = 0,
P−,−(n1, n2) = (v1r1d2 + v2r2d1)n1n2/(NrNd),
P+,−(n1, n2) = ω1r1n1 · d2n2/(NrNd),
P−,+(n1, n2) = ω2r2n2 · d1n1/(NrNd),
P−2,0(n1, n2) = v1r1d1n21/(NrNd),
P 0,−2(n1, n2) = v2r2d2n22/(NrNd), (15)
where P−2,0 is the probability to gain two S1 in a generation. Similarly,
P 0,−2 stands for the probability to gain two S2’s. Notice that due to con-
stant population assumption we have replaced differentiated cell population nD
by N − n1 − n2.
The probability of composite events from Fig. 3 modifies only the transition
probability, P 0,+,
P 0,+ → P 0,+ + q(N − n1 − n2)2/(NrNd), (16)
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while the denominator, Nr, is changed to,
Nr = r1n1 + r2n2 + q(N − n1 − n2), (17)
applied to all P (±,±)’s.
The dynamics of average values for frequencies 〈x1(t)〉 and 〈x2(t)〉 can be
derived using the master equation, by inserting average frequencies as,
〈x1(t)〉 = 1
N
∑
n1,n2
n1φ(n1, n2; t),
〈x2(t)〉 = 1
N
∑
n1,n2
n2φ(n1, n2; t),
(18)
into master equation,
1
N
∂
∂t
∑
n1,n2
n1φ(n1, n2; t)
=
∑
n1,n2
n1(
∑
α,β
Pα,β(n1 − α, n2 − β)φ(n1 − α, n2 − β; t))
− (
∑
α,β
Pα,β(n1, n2))φ(n1, n2; t), (19)
where α, β = {±1,±2} and φ(−1, n2) = φ(n1,−) = φ(−2, n2) = φ(n1,−2) = 0.
By shifting the sum over n’s by α and β in the first term of above equation we
arrive at ,
d〈x1(t)〉
dt
= 〈a1(x1, x2)〉,
d〈x2(t)〉
dt
= 〈a2(x1, x2)〉,
(20)
where,
a1(x1, x2) =
∑
α
P+,α − P−,α − 2P−2,0, α = {0,+,−} ,
a2(x1, x2) =
∑
α
Pα,+ − Pα,− − 2P 0,−2, α = {0,+,−} .
(21)
This will lead to a much simpler form for the time evolution of average
population frequencies. Thus in the large population limits we have Eq. 4.
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6. Appendix B: Analytical Result for Time to Fixation
Eq. 4 can be exactly integrated to give the time to fixation. For d1,2,D = 1.0
we obtain,
ln
(
x1,f
x1,i
)
− 1
r
ln
(
x2,f
x2,i
)
=
(r − 1) · t
r
(22)
For a fixation process values of initial and final conditions are,
x2,i =
1
N
x1,i = 1− 1
N
x2,f = α
(
1− 1
N
)
x1,f =
α
N
(23)
These conditions come from the constraints x1,i + x2,i + xD,f = 1. The initial
number of differentiated cells are assumed to be zero, and the final number of
differentiated cells is assumed to be x∗D = 1− α while assuming x1,f = α/N .
The fixation time now reads,
tF =
r + 1
r − 1 · lnN − lnα,
tF = tMoran − lnα. (24)
Notice that the the second term which represents the effect of differentiation,
is positive as α = 1− u− 2v is always less than one. We also have tF → ∞ as
α→ 0, which is the case when u, v → 1/3.
Similar result can be obtained for the non-symmetric situation where the
differentiation rates are not equal, i.e., α1 6= α2. Integrating the above equation
and using the initial conditions similar to Eq. 23,
x2,i =
1
N
x1,i = 1− 1
N
x2,f = α2
(
1− 1N
)
x1, f =
α2
N
(25)
The (approximate) result for the fixation time is,
tF =
(
rα2 + α1
rα2 − α1
)
lnN − lnα2. (26)
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